Sanctuary Advisors’s Novo Nordisk NVO Stock Holding History

Sanctuary Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.82M	Buy	239,948 +29,581	+14%	+$1.4M	0.05%	400
2025 Q4	$10.7M	Sell	210,367 -3,481	-2%	-$178K	0.06%	328
2025 Q3	$11.9M	Sell	213,848 -53,171	-20%	-$3.11M	0.07%	296
2025 Q2	$18.4M	Sell	267,019 -33,357	-11%	-$2.27M	0.11%	192
2025 Q1	$20.9M	Sell	300,376 -4,480	-1%	-$370K	0.15%	162
2024 Q4	$26M	Buy	304,856 +11,967	+4%	+$1.29M	0.16%	127
2024 Q3	$30.8M	Buy	292,889 +1,130	+0.4%	+$151K	0.19%	110
2024 Q2	$37M	Buy	+291,759	New	+$38.7M	0.27%	70

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sanctuary Advisors's NVO Position: Q1 2026 in Review

Sanctuary Advisors increased its Novo Nordisk (NVO) stake by 14% in Q1 2026, buying an estimated $1.4M and bringing the position to 239,948 shares worth $8.82M. The position accounts for 0.05% of the portfolio, ranked #400.

Sanctuary Advisors first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $37M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Sanctuary Advisors held 239,948 shares of Novo Nordisk worth $8.82M as of Q1 2026.
Sanctuary Advisors bought 29,581 Novo Nordisk shares in Q1 2026, an estimated $1.4M.
Novo Nordisk made up 0.05% of Sanctuary Advisors's portfolio in Q1 2026, its #400 holding.
Sanctuary Advisors first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
Sanctuary Advisors's Novo Nordisk position peaked at $37M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.